{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:32:23Z","timestamp":1767713543646,"version":"3.40.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Henan Provincial Science and Technology Association Youth Talent Promotion Project","award":["2023HYTP039"],"award-info":[{"award-number":["2023HYTP039"]}]},{"name":"Co-operation Research Plan of Medical Science and Technology of Henan Province","award":["LHGJ20220409"],"award-info":[{"award-number":["LHGJ20220409"]}]},{"name":"Key science and technology project s of Henan Province","award":["232102311048"],"award-info":[{"award-number":["232102311048"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-99625-1","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:03:48Z","timestamp":1746183828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of a radiomic model to predict CEACAM1 expression and prognosis in ovarian cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Xiaoxue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangfang","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruopeng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"99625_CR1","doi-asserted-by":"publisher","first-page":"868","DOI":"10.5306\/wjco.v11.i11.868","volume":"11","author":"L Feeney","year":"2020","unstructured":"Feeney, L., Harley, I. J., McCluggage, W. G., Mullan, P. B. & Beirne, J. P. Liquid biopsy in ovarian cancer: catching the silent killer before it strikes. World J. Clin. Oncol. 11, 868\u2013889. https:\/\/doi.org\/10.5306\/wjco.v11.i11.868 (2020).","journal-title":"World J. Clin. Oncol."},{"key":"99625_CR2","doi-asserted-by":"publisher","unstructured":"Jennifer, A., Iptissem, N., Aur\u00e9lie, R., Philippe, K. & Marc, A. J. The place of secondary complete cytoreductive surgery in advanced ovarian cancer. Horm. Mol. Biol. Clin. Investig. 41 https:\/\/doi.org\/10.1515\/hmbci-2019-0030 (2019).","DOI":"10.1515\/hmbci-2019-0030"},{"key":"99625_CR3","doi-asserted-by":"publisher","first-page":"972","DOI":"10.6004\/jnccn.2022.0047","volume":"20","author":"DK Armstrong","year":"2022","unstructured":"Armstrong, D. K. et al. NCCN Guidelines\u00ae insights: ovarian cancer, version 3.2022. J. Natl. Compr. Canc Netw. 20, 972\u2013980. https:\/\/doi.org\/10.6004\/jnccn.2022.0047 (2022).","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"99625_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bpobgyn.2016.12.001","volume":"41","author":"T Grunewald","year":"2017","unstructured":"Grunewald, T. & Ledermann, J. A. Targeted therapies for ovarian Cancer. Best Pract. Res. Clin. Obstet. Gynaecol. 41, 139\u2013152. https:\/\/doi.org\/10.1016\/j.bpobgyn.2016.12.001 (2017).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"99625_CR5","doi-asserted-by":"publisher","unstructured":"Morand, S., Devanaboyina, M., Staats, H., Stanbery, L. & Nemunaitis, J. Ovarian Cancer immunotherapy and personalized medicine. Int. J. Mol. Sci. 22 https:\/\/doi.org\/10.3390\/ijms22126532 (2021).","DOI":"10.3390\/ijms22126532"},{"key":"99625_CR6","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","volume":"25","author":"O Kopper","year":"2019","unstructured":"Kopper, O. et al. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity. Nat. Med. 25, 838\u2013849. https:\/\/doi.org\/10.1038\/s41591-019-0422-6 (2019).","journal-title":"Nat. Med."},{"key":"99625_CR7","doi-asserted-by":"publisher","first-page":"188503","DOI":"10.1016\/j.bbcan.2021.188503","volume":"1875","author":"M Zhang","year":"2021","unstructured":"Zhang, M., Cheng, S., Jin, Y., Zhao, Y. & Wang, Y. Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer. Biochim. Biophys. Acta Rev. Cancer. 1875, 188503. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188503 (2021).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"99625_CR8","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1007\/s00330-020-06937-z","volume":"30","author":"R Forstner","year":"2020","unstructured":"Forstner, R. Early detection of ovarian cancer. Eur. Radiol. 30, 5370\u20135373. https:\/\/doi.org\/10.1007\/s00330-020-06937-z (2020).","journal-title":"Eur. Radiol."},{"key":"99625_CR9","doi-asserted-by":"publisher","first-page":"111297","DOI":"10.1016\/j.ejrad.2024.111297","volume":"171","author":"C Maino","year":"2024","unstructured":"Maino, C. et al. Radiomics and liver: where we are and where we are headed? Eur. J. Radiol. 171, 111297. https:\/\/doi.org\/10.1016\/j.ejrad.2024.111297 (2024).","journal-title":"Eur. J. Radiol."},{"key":"99625_CR10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1186\/s12967-024-05393-3","volume":"22","author":"G Wang","year":"2024","unstructured":"Wang, G. et al. CT-based radiomics nomogram to predict proliferative hepatocellular carcinoma and explore the tumor microenvironment. J. Transl Med. 22, 683. https:\/\/doi.org\/10.1186\/s12967-024-05393-3 (2024).","journal-title":"J. Transl Med."},{"key":"99625_CR11","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.semcancer.2020.04.002","volume":"72","author":"A Conti","year":"2021","unstructured":"Conti, A., Duggento, A., Indovina, I., Guerrisi, M. & Toschi, N. Radiomics in breast cancer classification and prediction. Semin Cancer Biol. 72, 238\u2013250. https:\/\/doi.org\/10.1016\/j.semcancer.2020.04.002 (2021).","journal-title":"Semin Cancer Biol."},{"key":"99625_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.semcancer.2023.05.004","volume":"93","author":"M Chen","year":"2023","unstructured":"Chen, M., Copley, S. J., Viola, P., Lu, H. & Aboagye, E. O. Radiomics and artificial intelligence for precision medicine in lung cancer treatment. Semin Cancer Biol. 93, 97\u2013113. https:\/\/doi.org\/10.1016\/j.semcancer.2023.05.004 (2023).","journal-title":"Semin Cancer Biol."},{"key":"99625_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1051\/medsci\/2009253247","volume":"25","author":"AL Nouvion","year":"2009","unstructured":"Nouvion, A. L. & Beauchemin, N. [CEACAM1 as a central modulator of metabolism, tumor progression, angiogenesis and immunity]. Med. Sci. (Paris). 25, 247\u2013252. https:\/\/doi.org\/10.1051\/medsci\/2009253247 (2009).","journal-title":"Med. Sci. (Paris)"},{"key":"99625_CR14","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10555-013-9444-6","volume":"32","author":"N Beauchemin","year":"2013","unstructured":"Beauchemin, N. & Arabzadeh, A. Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis. Cancer Metastasis Rev. 32, 643\u2013671. https:\/\/doi.org\/10.1007\/s10555-013-9444-6 (2013).","journal-title":"Cancer Metastasis Rev."},{"key":"99625_CR15","doi-asserted-by":"publisher","first-page":"e2103230","DOI":"10.1002\/advs.202103230","volume":"9","author":"SKY To","year":"2022","unstructured":"To, S. K. Y. et al. A selective \u03b2-Catenin-Metadherin\/CEACAM1-CCL3 Axis mediates metastatic heterogeneity upon Tumor-Macrophage interaction. Adv. Sci. (Weinh). 9, e2103230. https:\/\/doi.org\/10.1002\/advs.202103230 (2022).","journal-title":"Adv. Sci. (Weinh)"},{"key":"99625_CR16","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s12094-017-1656-8","volume":"19","author":"Y Xu","year":"2017","unstructured":"Xu, Y., Zhang, H., Huang, Y., Rui, X. & Zheng, F. Role of TIM-3 in ovarian cancer. Clin. Transl Oncol. 19, 1079\u20131083. https:\/\/doi.org\/10.1007\/s12094-017-1656-8 (2017).","journal-title":"Clin. Transl Oncol."},{"key":"99625_CR17","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2967\/jnumed.118.222893","volume":"61","author":"ME Mayerhoefer","year":"2020","unstructured":"Mayerhoefer, M. E. et al. Introduction to radiomics. J. Nucl. Med. 61, 488\u2013495. https:\/\/doi.org\/10.2967\/jnumed.118.222893 (2020).","journal-title":"J. Nucl. Med."},{"key":"99625_CR18","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.2174\/1573405618666220516122145","volume":"18","author":"P Liu","year":"2022","unstructured":"Liu, P., Liang, X., Liao, S. & Lu, Z. Pattern classification for ovarian tumors by integration of radiomics and deep learning features. Curr. Med. Imaging. 18, 1486\u20131502. https:\/\/doi.org\/10.2174\/1573405618666220516122145 (2022).","journal-title":"Curr. Med. Imaging"},{"key":"99625_CR19","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1007\/s00261-020-02820-z","volume":"46","author":"S Nougaret","year":"2021","unstructured":"Nougaret, S. et al. Radiomics and radiogenomics in ovarian cancer: a literature review. Abdom. Radiol. (NY). 46, 2308\u20132322. https:\/\/doi.org\/10.1007\/s00261-020-02820-z (2021).","journal-title":"Abdom. Radiol. (NY)"},{"key":"99625_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.diii.2022.10.008","volume":"104","author":"C Xue","year":"2023","unstructured":"Xue, C., Zhou, Q., Xi, H., Zhou, J. & Radiomics A review of current applications and possibilities in the assessment of tumor microenvironment. Diagn. Interv Imaging. 104, 113\u2013122. https:\/\/doi.org\/10.1016\/j.diii.2022.10.008 (2023).","journal-title":"Diagn. Interv Imaging"},{"key":"99625_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13058-022-01516-0","volume":"24","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. Radiomics predicts the prognosis of patients with locally advanced breast cancer by reflecting the heterogeneity of tumor cells and the tumor microenvironment. Breast Cancer Res. 24, 20. https:\/\/doi.org\/10.1186\/s13058-022-01516-0 (2022).","journal-title":"Breast Cancer Res."},{"key":"99625_CR22","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013462. https:\/\/doi.org\/10.1093\/nar\/gkv1070 (2016).","journal-title":"Nucleic Acids Res."},{"key":"99625_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"99625_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.intimp.2018.02.016","volume":"57","author":"L Li","year":"2018","unstructured":"Li, L., Ma, Y., Xu, Y. & Maerkeya, K. TIM-3 expression identifies a distinctive PD-1(+) follicular helper T cell subset, with reduced Interleukin 21 production and B cell help function in ovarian cancer patients. Int. Immunopharmacol. 57, 139\u2013146. https:\/\/doi.org\/10.1016\/j.intimp.2018.02.016 (2018).","journal-title":"Int. Immunopharmacol."},{"key":"99625_CR25","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.1038\/ncomms7217","volume":"6","author":"V Khairnar","year":"2015","unstructured":"Khairnar, V. et al. CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production. Nat. Commun. 6, 6217. https:\/\/doi.org\/10.1038\/ncomms7217 (2015).","journal-title":"Nat. Commun."},{"key":"99625_CR26","doi-asserted-by":"publisher","first-page":"6537","DOI":"10.4049\/jimmunol.166.11.6537","volume":"166","author":"R Kammerer","year":"2001","unstructured":"Kammerer, R., Stober, D., Singer, B. B., Obrink, B. & Reimann, J. Carcinoembryonic antigen-related cell adhesion molecule 1 on murine dendritic cells is a potent regulator of T cell stimulation. J. Immunol. 166, 6537\u20136544. https:\/\/doi.org\/10.4049\/jimmunol.166.11.6537 (2001).","journal-title":"J. Immunol."},{"key":"99625_CR27","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1080\/14737140.2016.1178576","volume":"16","author":"ML Drakes","year":"2016","unstructured":"Drakes, M. L. & Stiff, P. J. Understanding dendritic cell immunotherapy in ovarian cancer. Expert Rev. Anticancer Ther. 16, 643\u2013652. https:\/\/doi.org\/10.1080\/14737140.2016.1178576 (2016).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"99625_CR28","doi-asserted-by":"publisher","first-page":"39179","DOI":"10.1074\/jbc.M608864200","volume":"281","author":"Q Yu","year":"2006","unstructured":"Yu, Q. et al. CEACAM1 (CD66a) promotes human monocyte survival via a phosphatidylinositol 3-kinase- and AKT-dependent pathway. J. Biol. Chem. 281, 39179\u201339193. https:\/\/doi.org\/10.1074\/jbc.M608864200 (2006).","journal-title":"J. Biol. Chem."},{"key":"99625_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1158\/1078-0432.Ccr-22-2877","volume":"29","author":"S Chow","year":"2023","unstructured":"Chow, S., Dorigo, O. & Monocytes A promising new TRAIL in ovarian Cancer cell therapy. Clin. Cancer Res. 29, 299\u2013301. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-22-2877 (2023).","journal-title":"Clin. Cancer Res."},{"key":"99625_CR30","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1002\/eji.201242676","volume":"43","author":"S Hosomi","year":"2013","unstructured":"Hosomi, S. et al. CEACAM1 on activated NK cells inhibits NKG2D-mediated cytolytic function and signaling. Eur. J. Immunol. 43, 2473\u20132483. https:\/\/doi.org\/10.1002\/eji.201242676 (2013).","journal-title":"Eur. J. Immunol."},{"key":"99625_CR31","doi-asserted-by":"publisher","unstructured":"Greppi, M. et al. Strengthening the antitumor NK cell function for the treatment of ovarian Cancer. Int. J. Mol. Sci. 20 https:\/\/doi.org\/10.3390\/ijms20040890 (2019).","DOI":"10.3390\/ijms20040890"},{"key":"99625_CR32","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.intimp.2016.12.024","volume":"43","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Co-expression of TIM-3 and CEACAM1 promotes T cell exhaustion in colorectal cancer patients. Int. Immunopharmacol. 43, 210\u2013218. https:\/\/doi.org\/10.1016\/j.intimp.2016.12.024 (2017).","journal-title":"Int. Immunopharmacol."},{"key":"99625_CR33","doi-asserted-by":"publisher","unstructured":"Muthuswamy, R. et al. CXCR6 by increasing retention of memory CD8(+) T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer. J. Immunother Cancer. 9 https:\/\/doi.org\/10.1136\/jitc-2021-003329 (2021).","DOI":"10.1136\/jitc-2021-003329"},{"key":"99625_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1517\/14728220903512983","volume":"14","author":"BM Nolen","year":"2010","unstructured":"Nolen, B. M. & Lokshin, A. E. Targeting CCL11 in the treatment of ovarian cancer. Expert Opin. Ther. Targets. 14, 157\u2013167. https:\/\/doi.org\/10.1517\/14728220903512983 (2010).","journal-title":"Expert Opin. Ther. Targets"},{"key":"99625_CR35","doi-asserted-by":"publisher","unstructured":"Drakes, M. L. & Stiff, P. J. Regulation of ovarian Cancer prognosis by immune cells in the tumor microenvironment. Cancers (Basel). 10 https:\/\/doi.org\/10.3390\/cancers10090302 (2018).","DOI":"10.3390\/cancers10090302"},{"key":"99625_CR36","doi-asserted-by":"publisher","first-page":"23210","DOI":"10.18632\/aging.203613","volume":"13","author":"Q Tan","year":"2021","unstructured":"Tan, Q., Liu, H., Xu, J., Mo, Y. & Dai, F. Integrated analysis of tumor-associated macrophage infiltration and prognosis in ovarian cancer. Aging (Albany NY). 13, 23210\u201323232. https:\/\/doi.org\/10.18632\/aging.203613 (2021).","journal-title":"Aging (Albany NY)"},{"key":"99625_CR37","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1080\/08820139.2016.1186689","volume":"45","author":"M Singh","year":"2016","unstructured":"Singh, M., Loftus, T., Webb, E., Benencia, F. & Minireview Regulatory T cells and ovarian Cancer. Immunol. Invest. 45, 712\u2013720. https:\/\/doi.org\/10.1080\/08820139.2016.1186689 (2016).","journal-title":"Immunol. Invest."},{"key":"99625_CR38","doi-asserted-by":"publisher","first-page":"108747","DOI":"10.1016\/j.compbiomed.2024.108747","volume":"178","author":"S Ma","year":"2024","unstructured":"Ma, S. et al. Identification of a G-protein coupled receptor-related gene signature through bioinformatics analysis to construct a risk model for ovarian cancer prognosis. Comput. Biol. Med. 178, 108747. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108747 (2024).","journal-title":"Comput. Biol. Med."},{"key":"99625_CR39","doi-asserted-by":"publisher","first-page":"216891","DOI":"10.1016\/j.canlet.2024.216891","volume":"591","author":"JH Ha","year":"2024","unstructured":"Ha, J. H. et al. Deciphering a GPCR-lncrna-miRNA nexus: identification of an aberrant therapeutic target in ovarian cancer. Cancer Lett. 591, 216891. https:\/\/doi.org\/10.1016\/j.canlet.2024.216891 (2024).","journal-title":"Cancer Lett."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99625-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99625-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99625-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T08:32:46Z","timestamp":1746520366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99625-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99625"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99625-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Institutional Review Board approval was not required because data sourced from public network bioinformatics databases.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"15259"}}